Sivik Global Healthcare’s Stevanato STVN Stock Holding History

Sivik Global Healthcare’s Portfolio STVN Stock Details STVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-85,000	Closed	-$2.19M	–	54
2025 Q3	$2.19M	Buy	+85,000	New	+$2.1M	0.64%	42
2024 Q4	–	Sell	-140,000	Closed	-$2.8M	–	45
2024 Q3	$2.8M	Buy	+140,000	New	+$2.82M	1.19%	32
2024 Q2	–	Sell	-83,039	Closed	-$2.67M	–	49
2024 Q1	$2.67M	Buy	83,039 +3,039	+4%	+$92.5K	0.63%	43
2023 Q4	$2.18M	Buy	80,000 +3,928	+5%	+$113K	0.91%	38
2023 Q3	$2.26M	Buy	76,072 +6,072	+9%	+$190K	1.14%	33
2023 Q2	$2.27M	Buy	+70,000	New	+$1.97M	0.53%	37

Other funds holding STVN

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Sivik Global Healthcare's STVN Position: Q4 2025 in Review

Sivik Global Healthcare sold out of Stevanato (STVN) in Q4 2025, closing a stake of 85,000 shares — an estimated $2.19M sold.

Sivik Global Healthcare first reported a position in STVN in Q2 2023 and held it in 6 quarters. The position peaked at $2.8M in Q3 2024. 139 funds tracked by Wall St. Rank hold STVN as of Q4 2025.

Sivik Global Healthcare reported no remaining Stevanato position as of Q4 2025 after selling out during the quarter.
Sivik Global Healthcare sold 85,000 Stevanato shares in Q4 2025, an estimated $2.19M.
Sivik Global Healthcare first reported a position in Stevanato in Q2 2023 and held it in 6 quarters.
Sivik Global Healthcare's Stevanato position peaked at $2.8M in Q3 2024.
139 funds tracked by Wall St. Rank held Stevanato as of Q4 2025.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.